非增强CT的ASPECTS评分可能改变DAWN研究中动脉内治疗的效果
该研究基于DAWN试验数据,分析基线非增强CT(NCCT)的ASPECTS评分是否改变动脉内治疗(IAT)的效果。结果显示,NCCT ASPECTS与IAT存在显著交互作用,高ASPECTS患者从IAT获益更大,而弥散加权成像ASPECTS未见显著交互作用。
要点
- NCCT ASPECTS与IAT对90天效用加权mRS和mRS 0-2存在显著交互作用。
- NCCT ASPECTS 7-10组IAT获益显著(OR 7.50),0-6组呈双向效应。
- DWI ASPECTS未显示显著的治疗交互作用。
核心结论
- 基线NCCT ASPECTS可能改变DAWN试验中IAT的治疗效果,高ASPECTS与更大获益相关。
研究设计与样本
- 基于DAWN试验的队列分析,共205例受试者,其中123例(60%)有NCCT ASPECTS,82例(40%)有DWI ASPECTS。
主要发现
- NCCT ASPECTS与IAT对90天效用加权mRS存在显著序数交互作用(交互P=0.04),对mRS 0-2也存在显著交互作用(交互P=0.02),高NCCT ASPECTS时IAT效果更明显。
- 二分类NCCT ASPECTS(0-6 vs 7-10)与治疗交互仅对mRS 0-2显著(交互P=0.04),ASPECTS 7-10组治疗获益更大(OR 7.50 [2.71-20.77]),ASPECTS 0-6组OR为0.48 [0.04-5.40]。
- NCCT ASPECTS 0-6组观察到双向治疗效应:治疗与更多mRS 0-3结局相关(50% vs 25%),也与更多mRS 5-6结局相关(40% vs 25%)。
- DWI ASPECTS未显著改变IAT效果。
关键数值与推荐
- NCCT ASPECTS序数交互:90天效用加权mRS交互P=0.04,mRS 0-2交互P=0.02。
- 二分类NCCT ASPECTS交互仅对mRS 0-2显著(交互P=0.04),ASPECTS 7-10组OR 7.50 [2.71-20.77],0-6组OR 0.48 [0.04-5.40]。
- NCCT ASPECTS 0-6组:mRS 0-3为50% vs 25%,mRS 5-6为40% vs 25%。
临床怎么用
- 在延长时间窗内,可参考基线NCCT ASPECTS评估IAT获益可能性,高ASPECTS(7-10)患者可能获益更大。
- NCCT ASPECTS 0-6患者IAT效果呈双向性,需个体化权衡获益与风险。
局限性
- 研究为DAWN试验的事后分析,样本量有限(205例),NCCT亚组123例。
- DWI ASPECTS亚组仅82例,交互作用检验效能可能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- It is unknown whether noncontrast computed tomography (NCCT) can identify patients who will benefit from intra-arterial treatment (IAT) in the extended time window. We sought to characterize baseline Alberta Stroke Program Early CT Score (ASPECTS) in DAWN (DWI or CTP Assessment With Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention With Trevo) and to assess whether ASPECTS modified IAT effect. Methods- Core lab adjudicated ASPECTS scores were analyzed. The trial cohort was divided into 2 groups by qualifying imaging (computed tomography versus magnetic resonance imaging). ASPECTS-by-treatment interaction was tested for the trial coprimary end points (90-day utility-weighted modified Rankin Scale (mRS) score and mRS, 0-2), mRS 0 to 3, and ordinal mRS. ASPECTS was evaluated separately as an ordinal and a dichotomized (0-6 versus 7-10) variable. Results- Of 205 DAWN subjects, 123 (60%) had NCCT ASPECTS, and 82 (40%) had diffusion weighted imaging ASPECTS. There was a significant ordinal NCCT ASPECTS-by-treatment interaction for 90-day utility-weighted mRS (interaction P=0.04) and mRS 0 to 2 (interaction P=0.02). For both end points, IAT effect was more pronounced at higher NCCT ASPECTS. The dichotomized NCCT ASPECTS-by-treatment interaction was significant only for mRS 0 to 2 (interaction P=0.04), where greater treatment benefit was seen in the ASPECTS 7 to 10 group (odds ratio, 7.50 [2.71-20.77] versus odds ratio, 0.48 [0.04-5.40]). A bidirectional treatment effect was observed in the NCCT ASPECTS 0 to 6 group, with treatment associated with not only more mRS 0 to 3 outcomes (50% versus 25%) but also more mRS 5 to 6 outcomes (40% versus 25%). There was no significant modification of IAT effect by diffusion weighted imaging ASPECTS. Conclusions- Baseline NCCT ASPECTS appears to modify IAT effect in DAWN. Higher NCCT ASPECTS was associated with greater benefit from IAT. No treatment interaction was observed for diffusion weighted imaging ASPECTS.
引用
- Bhuva P, Yoo AJ, Jadhav AP, et al. Noncontrast Computed Tomography Alberta Stroke Program Early CT Score May Modify Intra-Arterial Treatment Effect in DAWN. Stroke. 2019. PMID: 31345135. doi:10.1161/STROKEAHA.118.024583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。